TY - JOUR
T1 - Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms
T2 - Results from an exploratory outcome of a randomized placebo-controlled trial
AU - Rabinowitz, Jonathan
AU - Badescu, Stefan
AU - Palamarchuk, Pavel
AU - Filyk, Viktor
AU - Voloshchuk, Anatolii
AU - Rud, Vadym
AU - Melnyk, Ellina
AU - Skrypnikov, Andrii
AU - Davidson, Michael
AU - Saoud, Jay
AU - Luthringer, Remy
N1 - Funding Information:
The study phase 2b clinical trial was funded by Minerva Neurosciences.
PY - 2019/9
Y1 - 2019/9
UR - http://www.scopus.com/inward/record.url?scp=85071379553&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2019.07.029
DO - 10.1016/j.schres.2019.07.029
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 31375316
SN - 0920-9964
VL - 211
SP - 103
EP - 104
JO - Schizophrenia Research
JF - Schizophrenia Research
ER -